Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
疏糖颗粒治疗2型糖尿病(气阴两虚兼肝郁证)随机、双盲、 剂量对照、多中心Ⅱa期临床试验
[Translation] A randomized, double-blind, dose-controlled, multicenter phase IIa clinical trial of Shutang granules in the treatment of type 2 diabetes (Qi and Yin deficiency combined with liver depression syndrome)
采用随机、双盲、剂量对照、多中心临床试验设计方法,评价试验药物用于治疗2型糖尿病(气阴两虚兼肝郁证)有效性和安全性的探索性研究。
[Translation] A randomized, double-blind, dose-controlled, multicenter clinical trial design was used to conduct an exploratory study to evaluate the efficacy and safety of the experimental drug in the treatment of type 2 diabetes (Qi and Yin deficiency with liver depression syndrome).
100 Clinical Results associated with Hebei Zhongtang Medicine Co., Ltd.
0 Patents (Medical) associated with Hebei Zhongtang Medicine Co., Ltd.
100 Deals associated with Hebei Zhongtang Medicine Co., Ltd.
100 Translational Medicine associated with Hebei Zhongtang Medicine Co., Ltd.